GPCR - Structure Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

4.974B

Cash

436.4M

Avg Qtr Burn

-23.32M

Short % of Float

9.63%

Insider Ownership

4.56%

Institutional Own.

81.49%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GSBR-1290 (GLP-1R agonists) Details Type 2 diabetes, Obesity	Phase 2b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ANPA-0073 (APJ agonist) Details Pulmonary arterial hypertension, Idiopathic pulmonary fibrosis	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LTSE-2578 Details Idiopathic pulmonary fibrosis	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.